CCM
AUPH icon

Consonance Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Consonance Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,621,325
Closed -$75.1M – 30
2020
Q2 		$75.1M Sell
4,621,325
-2,288,049
-33% -$36.6M 4.5% 11
2020
Q1 		$100M Buy
6,909,374
+283,703
+4% +$5M 7.47% 3
2019
Q4 		$134M Buy
6,625,671
+4,064,402
+159% +$37.4M 8.19% 1
2019
Q3 		$13.7M Sell
2,561,269
-1,661,289
-39% -$10.1M 1.35% 21
2019
Q2 		$27.8M Hold
4,222,558
– – 1.97% 19
2019
Q1 		$27.4M Buy
4,222,558
+4,212,558
+42,126% +$27.9M 1.73% 18
2018
Q4 		$68K Buy
+10,000
New +$57.7K 0.01% 24

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Consonance Capital Management's AUPH Position: Q3 2020 in Review

Consonance Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2020, closing a stake of 4,621,325 shares — an estimated $75.1M sold.

Consonance Capital Management first reported a position in AUPH in Q4 2018 and held it in 7 quarters. The position peaked at $134M in Q4 2019. 145 funds tracked by Wall St. Rank hold AUPH as of Q3 2020.

  • Consonance Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Consonance Capital Management sold 4,621,325 Aurinia Pharmaceuticals shares in Q3 2020, an estimated $75.1M.
  • Consonance Capital Management first reported a position in Aurinia Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • Consonance Capital Management's Aurinia Pharmaceuticals position peaked at $134M in Q4 2019.
  • 145 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2020.

Based on Consonance Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.